NCT06096194

Brief Summary

This is double-blind, controlled fiel trial, to compare fortified egg with D3-or 25(OH)D3 and non-fortified eggs in healthy preschool-age children 12 to 60 months of age, affiliated to day-care centers at Secretaria de Desarrollo Social (SEDESOL). The study aims to answer are:

  • Children would be given for breakfast fortified egg/non-foritfied egg three times per week for 12 weeks.
  • Blood samples will be taken at baseline and at the end of study.
  • Anthropometric meassurements weight /height will be taken at baseline and at end of study.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
275

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2018

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 15, 2018

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2018

Completed
1.1 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 21, 2019

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

September 4, 2023

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 23, 2023

Completed
Last Updated

October 23, 2023

Status Verified

October 1, 2023

Enrollment Period

5 months

First QC Date

September 4, 2023

Last Update Submit

October 19, 2023

Conditions

Keywords

Vitamin D3enhanced eggVitamin D3-enhanced egg25-Hydroxyvitamin D3 DeficiencysupplementationMexicoChildren

Outcome Measures

Primary Outcomes (1)

  • Serum 25-OH-D

    nmol/L

    At baseline and at 12 weeks of intervention

Secondary Outcomes (1)

  • Serum PTH

    At baseline and at 12 weeks of intervention

Other Outcomes (7)

  • Insulin

    At baseline and at 12 weeks of intervention

  • Weight

    At baseline and at 12 weeks of intervention

  • Height

    At baseline and at 12 weeks of intervention

  • +4 more other outcomes

Study Arms (2)

vitamin D3-enhanced egg

EXPERIMENTAL

The experimental group consumed an vitamin D3-enhanced egg (\~ 400 IU). The randomization unit was the take care SEDESOL centers. All children in 3 day-care centers were given one vitamin D3-enhanced egg at breakfast, 3 times a week for 12 weeks (Monday, Wednesday and Friday).

Dietary Supplement: vitamin D-enhanced egg

Control

PLACEBO COMPARATOR

The control group consumed unfortified egg (\~ 43 IU Vitamin D). The randomization unit was the 6 day-care centers (SEDESOL). All children in 3 day-care centers were given unfortified egg at breakfast, 3 times a week for 12 weeks (Monday, Wednesday and Friday).

Other: Control

Interventions

vitamin D-enhanced eggDIETARY_SUPPLEMENT

In our study, the vitamin D3-enhanced eggs were produced by hens that received 23,500 IU of vitamin D3 per kg of feed. Which does not confer them any harm or danger of intoxication. This experiment was carried out at the Center for Teaching, Research and Extension in Poultry Production (CEIEPAv, FMVZ-UNAM) and lasted 40 weeks. This ensured that the hens eggs were enhanced with vitamin D achieving a final concentration of approximately 400 IU of vitamin D

vitamin D3-enhanced egg
ControlOTHER

Unfortified eggs were used for the control group with a concentration of approximately 43 IU of vitamin D

Control

Eligibility Criteria

Age12 Months - 59 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children of either sex, from 12 to 59 months of age who attend take care SEDESOL centers
  • Children who consume eggs within their usual diet at least 5 times per month
  • Childrens whose parents or legal guardian agree to participate in the study and sign an informed consent letter

You may not qualify if:

  • Children with an egg allergy
  • Chldren with hypersensitivity to vitamin D
  • Children who have taken vitamin D supplements in the past month

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Instituto Nacional de Salud Pública

Cuernavaca, Morelos, 62100, Mexico

Location

MeSH Terms

Conditions

Vitamin D DeficiencyVitamin D Hydroxylation-Deficient Rickets, Type 1B

Condition Hierarchy (Ancestors)

AvitaminosisDeficiency DiseasesMalnutritionNutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Mario E Flores Aldana, PhD

    National Institute of Public Health, Mexico

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
Two types of eggs. Control egg and fortified egg (vitamin D3-enhanced egg), only the researcher in charge of eggs production was not blinded
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Randomized Double Blind field trial
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Mario Flores-Aldana, MD, PhD Nutrition Surveillance, Director

Study Record Dates

First Submitted

September 4, 2023

First Posted

October 23, 2023

Study Start

July 15, 2018

Primary Completion

November 30, 2018

Study Completion

December 21, 2019

Last Updated

October 23, 2023

Record last verified: 2023-10

Data Sharing

IPD Sharing
Will not share

Locations